Source:http://linkedlifedata.com/resource/pubmed/id/20345905
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2010-4-23
|
pubmed:abstractText |
Lactoferrin (LF) has been implicated in innate immunity. Here we reveal the signal transduction pathway responsible for human LF (hLF)-triggered nuclear factor-kappaB (NF-kappaB) activation. Endotoxin-depleted hLF induces NF-kappaB activation at physiologically relevant concentrations in the human monocytic leukemia cell line, THP-1, and in mouse embryonic fibroblasts (MEFs). In MEFs, in which both tumor necrosis factor receptor-associated factor 2 (TRAF2) and TRAF5 are deficient, hLF causes NF-kappaB activation at a level comparable to that seen in wild-type MEFs, whereas TRAF6-deficient MEFs show significantly impaired NF-kappaB activation in response to hLF. TRAF6 is known to be indispensable in leading to NF-kappaB activation in myeloid differentiating factor 88 (MyD88)-dependent signaling pathways, while the role of TRAF6 in the MyD88-independent signaling pathway has not been clarified extensively. When we examined the hLF-dependent NF-kappaB activation in MyD88-deficient MEFs, delayed, but remarkable, NF-kappaB activation occurred as a result of the treatment of cells with hLF, indicating that both MyD88-dependent and MyD88-independent pathways are involved. Indeed, hLF fails to activate NF-kappaB in MEFs lacking Toll-like receptor 4 (TLR4), a unique TLR group member that triggers both MyD88-depependent and MyD88-independent signalings. Importantly, the carbohydrate chains from hLF are shown to be responsible for TLR4 activation. Furthermore, we show that lipopolysaccharide-induced cytokine and chemokine production is attenuated by intact hLF but not by the carbohydrate chains from hLF. Thus, we present a novel model concerning the biological function of hLF: hLF induces moderate activation of TLR4-mediated innate immunity through its carbohydrate chains; however, hLF suppresses endotoxemia by interfering with lipopolysaccharide-dependent TLR4 activation, probably through its polypeptide moiety.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Lactoferrin,
http://linkedlifedata.com/resource/pubmed/chemical/Lipopolysaccharides,
http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B,
http://linkedlifedata.com/resource/pubmed/chemical/Tlr4 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Toll-Like Receptor 4
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1742-4658
|
pubmed:author |
pubmed-author:AkiraShizuoS,
pubmed-author:AkiyamaTaishinT,
pubmed-author:AndoKenK,
pubmed-author:FujinoTomofumiT,
pubmed-author:FurusawaTomoyasuT,
pubmed-author:GohdaJinJ,
pubmed-author:HasegawaKeiichiK,
pubmed-author:HayakawaMakioM,
pubmed-author:InoueJun-IchiroJ,
pubmed-author:KikugawaKiyomiK,
pubmed-author:NakanoHiroyasuH,
pubmed-author:ShindoKen-IchiK,
pubmed-author:TakeuchiOsamuO
|
pubmed:issnType |
Electronic
|
pubmed:volume |
277
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2051-66
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:20345905-Animals,
pubmed-meshheading:20345905-Cattle,
pubmed-meshheading:20345905-Cell Line,
pubmed-meshheading:20345905-Humans,
pubmed-meshheading:20345905-Lactoferrin,
pubmed-meshheading:20345905-Lipopolysaccharides,
pubmed-meshheading:20345905-Mice,
pubmed-meshheading:20345905-NF-kappa B,
pubmed-meshheading:20345905-Signal Transduction,
pubmed-meshheading:20345905-Toll-Like Receptor 4
|
pubmed:year |
2010
|
pubmed:articleTitle |
Human lactoferrin activates NF-kappaB through the Toll-like receptor 4 pathway while it interferes with the lipopolysaccharide-stimulated TLR4 signaling.
|
pubmed:affiliation |
Tokyo University of Pharmacy and Life Sciences, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|